Covid-19 roundup: Non-Covid PhIII trials saw steep decline in 2020; Merck's pill is last choice among patients
New research shows how Covid-19 took a major bite out of clinical research in the US in the early days of the pandemic as non …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
